Following its endorsement from NICE (National Institute for Health and Care Excellence), the recently developed Enzalutamide (Xtandi®) has now become an NHS recommended treatment for thousands of prostate cancer patients throughout England, Wales and Northern Ireland; the development is widely welcomed, particularly by those patients for whom chemotherapy is unviable. […]
Value of PSA Prostate Screening Debate
With its timely discovery of aggressive cancers, the objective of PSA screening is to reduce the risk of cancer-related death, surely making it an unequivocally important weapon in our fight against cancer; some have now started to question the value of PSA screening and this has stirred a debate amongst […]
Research Show UroLift Outpatient Procedure Demonstrates Symptom Improvement for BPH
The innovative UroLift system used to treat patients diagnosed with BPH (Benign Prostatic Hyperplasia) has once again been proven to be a safe and effective treatment method, with the results of recent clinical research further evidencing symptomatic relief amongst patients; it’s also believed that patients receiving treatment for their symptoms, […]
Caribbean Islands Possible Poisoning By a Carcinogenic Pesticide
Following the historical widespread use of Chlordecone (originally marketed as Kepone) throughout Martinique, the carcinogenic pesticide is now found in the bloodstream of over ninety percent of residents on the French Caribbean island. Chlordecone has rendered fishing or crop cultivation inviable, due to its poisoning of the food and water, […]
iTind Treatment for BPH Enlarged Prostate Reaches Two Milestones
BPH (Benign prostatic hyperplasia) affects as many as 8 of 10 older men; this means that the prostate is enlarged and medical treatment is required to relieve the associated symptoms. Because it marginalises the risk of incurring associated side-effects (such as LUTS (Lower Urinary Tract Symptoms) or erectile dysfunction), iTind […]
Prostate Cancer Patients Swap Chemo for Precision Drugs during Pandemic
The COVID19 pandemic has placed an incalculable amount of pressure on the National Health Service and to help relieve this, NHS England has announced that patients with advanced prostate cancer can replace their hospital-based chemotherapy treatments, with highly specific hormone therapy medication that is self-administered at home. This essentially lessens […]